However, we confirmed recurrently mutated genes previously reported in studies that included enrichment for HRS cells, including known hotspot mutations and mutations with predicted consequences that are consistent with known Hodgkin lymphoma biology (e.g., inactivating mutations in SOCS-1 and TNFAIP3). This evidence concerns the gene TNFAIP3 and Hodgkins lymphoma.